Russia

A U.N. Declaration on Ending AIDS Should Have Been Easy. It Wasn’t.

Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.

An U.N. Declaration on Ending AIDS Should Have Been Easy. It Wasn’t.

Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.

EMA starts rolling review of Sputnik V COVID vaccine

With EU countries breaking ranks in order to get access to the Russian Sputnik V COVID-19 vaccine, the EMA has started a rolling review of the shot.  “EMA will assess Sputnik V’s compliance with the usual EU standards for effectiveness, safety and quality. While EMA cannot predict the overall timelines, it should take less time …

EMA starts rolling review of Sputnik V COVID vaccine Read More »

Your Wednesday Briefing

Syria’s economy in distress.

Your Wednesday Briefing

Syria’s economy in distress.

Your Wednesday Briefing

Syria’s economy in distress.

Your Wednesday Briefing

Syria’s economy in distress.

Your Wednesday Briefing

Syria’s economy in distress.

Your Wednesday Briefing

Syria’s economy in distress.

PharmaShots Weekly Snapshot (Feb 01-05, 2021)

Reistone Report Results for SHR0302 in P-II Study to Treat Ulcerative Colitis Published: Feb 5, 2020 | Tags: Reiston, Report, Result, SHR0302, P-II, Study, Treat, Ulcerative Colitis Enzene Receives Marketing Authorization for Teriparatide (biosimilar) in India Published: Feb 5, 2020 | Tags: Enzene, Receives, Marketing Authorization, Teriparatide (biosimilar), India Johnson & Johnson Reports EUA Submission …

PharmaShots Weekly Snapshot (Feb 01-05, 2021) Read More »

Russia’s Sputnik V Demonstrates 92% Efficacy Against COVID-19

Shots: The P-lll study involves assessing of Sputnik V vaccine vs PBO from 19,866 volunteers with COVID-19. The efficacy of the vaccine is 92% effective in fighting COVID-19 based on peer-reviewed late-stage trial results published in the lancet international medical journal Previous data from two-dose regimen of the vaccine based on two different viral vectors …

Russia’s Sputnik V Demonstrates 92% Efficacy Against COVID-19 Read More »

Sputnik V data in Lancet should end “fake news” on its efficacy, says RDIF

The publication of data backing Russia’s COVID-19 vaccine Sputnik V in a peer review journal should bring a campaign to discredit the shot to an end, says the head of the Russian Direct Investment Fund (RDIF). The new data – made available in The Lancet today – give the vaccine a protection rate of 91.6% …

Sputnik V data in Lancet should end “fake news” on its efficacy, says RDIF Read More »

Dr. Reddy’s to Divest Select Anti-Allergy brands to Dr. Reddy’s in Russia and Other CIS Countries

Shots: Dr. Reddy to acquire Glenmark’s brands Momat Rino (for Russia, Kazakhstan, and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan & Uzbekistan), Glenspray, and Glenspray Active (for Ukraine) along-with rights to the trademarks, dossiers, and patents for the mentioned territories The acquired products will further strengthen Dr. Reddy’s presence in the anti-allergy …

Dr. Reddy’s to Divest Select Anti-Allergy brands to Dr. Reddy’s in Russia and Other CIS Countries Read More »

Russian Sputnik COVID-19 vaccine ‘will cost less than $10 a dose’

The developer of Russia’s COVID-19 vaccine Sputnik V has pledged to make it available for less than $10 per dose – or $20 per two-dose course – on the same day as revealing new clinical data with the shot. Sputnik V’s efficacy has remained high at 91.4% according to the latest analysis, which comes from …

Russian Sputnik COVID-19 vaccine ‘will cost less than $10 a dose’ Read More »

Russia claims 92% efficacy for Sputnik COVID-19 shot

In the second positive piece of COVID-19 vaccine news in a week, Russia’s Sputnik V candidate has been shown to be 92% effective at the interim point of a 40,000-patient study. The preliminary assessment is based on 20 coronavirus cases split between the vaccinated and placebo arms of the study at 21 days, according to …

Russia claims 92% efficacy for Sputnik COVID-19 shot Read More »

Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot

Russia’s sovereign wealth fund has filed applications with the World Health Organization (WHO) that if approved could see the Sputnik V coronavirus vaccine backed for use in many countries around the world. The applications are for two WHO mechanisms, aimed at providing a route to market for vaccines, drugs and other healthcare products that answer …

Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot Read More »

Sanofi preps trials of second COVID-19 shot, as Russia approves another

Sanofi will shortly start human trials of a second coronavirus vaccine, developed with US biotech Translate Bio, after reporting that it stimulated antibodies against SARS-CoV-2 in preclinical testing. The French drugmaker’s Sanofi Pasteur vaccines division says it is planning a phase 1/2 trial of the mRNA-based vaccine, called MRT5500, before the end of the year. …

Sanofi preps trials of second COVID-19 shot, as Russia approves another Read More »

Oxford University Covid-19 vaccine firm denies Trump talks

AstraZeneca says it has not discussed ‘emergency use authorisation’ with the US Coronavirus – latest updates See all our coronavirus coverage The company manufacturing the Oxford University coronavirus vaccine has denied it is in talks with the Trump administration about fast-tracking its vaccine for emergency use ahead of November’s presidential elections. With both Russia and …

Oxford University Covid-19 vaccine firm denies Trump talks Read More »

Report: Russia says its Covid-19 vaccine ready for market despite no Phase III data

Russian President Vladimir Putin said a vaccine developed at a Moscow research institute that appears to still be in Phase I development among fewer than 100 participants had undergone all necessary tests.

UK ‘95% sure’ Russian hackers tried to steal coronavirus vaccine research

Minister says Britain and allies confident Russian intelligence was behind cyber-attacks Coronavirus – latest updates See all our coronavirus coverage The UK security minister James Brokenshire has said Britain is “more than 95%” sure that Russian state-sponsored hackers targeted UK, US and Canadian organisations involved in developing a coronavirus vaccine. Brokenshire said the National Cyber …

UK ‘95% sure’ Russian hackers tried to steal coronavirus vaccine research Read More »

Russian hackers suspected in Covid-19 vaccine intellectual property theft, report says

A joint report by cybersecurity agencies in the U.K. and Canada, endorsed by their U.S. counterparts, states that the hacker group Cozy Bear had been targeting organizations involved with Covid-19 vaccine development efforts.